雜志介紹

Breast Cancer Research雜志介紹

《Breast Cancer Research》是一本以(yi)(yi)English為主(zhu)的(de)(de)開放獲取國際優秀期刊(kan)，中(zhong)文名稱乳腺(xian)癌研究(jiu)，本刊(kan)主(zhu)要出版、報(bao)道醫(yi)學-ONCOLOGY領(ling)域的(de)(de)研究(jiu)動態以(yi)(yi)及在該(gai)(gai)領(ling)域取得的(de)(de)各方面的(de)(de)經驗和科(ke)研成果，介紹該(gai)(gai)領(ling)域有關(guan)本專業的(de)(de)最(zui)新進展，探(tan)討行(xing)業發展的(de)(de)思路和方法，以(yi)(yi)促進學術信息交流，提高(gao)行(xing)業發展。該(gai)(gai)刊(kan)已(yi)被國際權威數據庫SCIE收(shou)錄，為該(gai)(gai)領(ling)域相關(guan)學科(ke)的(de)(de)發展起到了良好的(de)(de)推(tui)動作用(yong)，也得到了本專業人員(yuan)的(de)(de)廣(guang)泛認可(ke)。該(gai)(gai)刊(kan)最(zui)新影響(xiang)因子為6.1，最(zui)新CiteScore 指數為12。

本刊近期中國學(xue)者發表的(de)論(lun)文主要有：

• Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6/STAT3 signaling

  Author: Liu, Heshu; Yan, Rui; Xiao, Zeru; Huang, Xuying; Yao, Jiannan; Liu, Jian; An, Guangyu; Ge, Yang

• MTX-PEG-modified CG/DMMA polymeric micelles for targeted delivery of doxorubicin to induce synergistic autophagic death against triple-negative breast cancer

  Author: Cao, Zhiwen; Liu, Rui; Li, Yang; Luo, Xinyi; Hua, Zhenglai; Wang, Xiangpeng; Xue, Zeyu; Zhang, Zhengjia; Lu, Cheng; Lu, Aiping; Liu, Yuanyan

• Association between human blood metabolome and the risk of breast cancer

  Author: Wang, Yu; Liu, Fanghua; Sun, Lulu; Jia, Yiming; Yang, Pinni; Guo, Daoxia; Shi, Mengyao; Wang, Aili; Chen, Guo-Chong; Zhang, Yonghong; Zhu, Zhengbao

• METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer

  Author: Ouyang, Dengjie; Hong, Tao; Fu, Mengdie; Li, Yitong; Zeng, Liyun; Chen, Qitong; He, Hongye; Wen, Ying; Cheng, Yan; Zhou, Meirong; Zou, Qiongyan; Yi, Wenjun

英文介紹

Breast Cancer Research雜志英文介紹

Breast Cancer Research is an international, peer-reviewed online journal, publishing original research, reviews, editorials and reports. Open access research articles of exceptional interest are published in all areas of biology and medicine relevant to breast cancer, including normal mammary gland biology, with special emphasis on the genetic, biochemical, and cellular basis of breast cancer. In addition to basic research, the journal publishes preclinical, translational and clinical studies with a biological basis, including Phase I and Phase II trials.